Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban for treatment of venous thrombosis in patients with cancer
2014-005439-15Phase 4Completed
- Sponsor
- Akershus University Hospital
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of apixaban in venous thromboembolism (VTE) and cancer, sponsored by Akershus University Hospital. Primary endpoint: Major or clinically relevant non-major bleeding at 6 months. Started Oct 2015; status: completed.
02
Drugs
apixaban
03
Conditions
venous thromboembolism (VTE)cancer
Beyond the preview
Go deeper on 2014-005439-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005439-15.